The mechanism of action of olaparib

1. The mechanism of action of olaparib

Olaparib is a polyadenosine diphosphate ribose polymerase (PARP) inhibitor. PARP enzymes play a key role in repairing DNA damage in cells. Normal cells have a variety of DNA repair mechanisms, and even if the function of PARP enzyme is inhibited to a certain extent, it can repair DNA damage through other ways to maintain the normal function of cells. However, tumor cells, unlike normal cells, tend to have abnormal DNA repair mechanisms and are more dependent on the PARP enzyme. Olaparib blocks the DNA damage repair process within tumor cells by inhibiting the activity of the PARP enzyme. As a result, tumor cells are unable to effectively repair DNA damage, and DNA damage accumulates, eventually leading to apoptosis. This unique mechanism of action makes olaparib highly effective in the treatment of tumors associated with DNA repair.

2. Therapeutic application of olaparib

1. Ovarian cancer treatment

Olaparib plays an important role in the treatment of ovarian cancer. Olaparib may be used as maintenance therapy in adults with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer after achieving a complete or partial response with platinum-based chemotherapy. Clinical studies have shown that olaparib can significantly prolong the progression-free survival and improve the quality of life of patients.

Olaparib also plays an important role in the first-line treatment of advanced ovarian cancer. First-line maintenance therapy with olaparib reduces the risk of disease progression or death in patients with advanced epithelial ovarian cancer harboring BRCA mutations.

2. Breast cancer treatment

For patients with advanced breast cancer who harbor BRCA1/2 gene mutations, olaparib can significantly reduce the recurrence and mortality rates of breast cancer. This opens up new treatment options for BRCA-mutated breast cancer patients, offering hope for long-term survival.

3. Potential applications for other cancers

In addition to ovarian and breast cancers, olaparib also has potential applications in the treatment of some other cancers. For example, in pancreatic cancer, lymphoma and other cancers, clinical trials of olaparib are ongoing, and preliminary results show some efficacy.